Equities research analysts predict that Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) will report earnings of ($0.21) per share for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Kitov Pharmaceuticals Holdings’ earnings. The company is scheduled to announce its next quarterly earnings results on Monday, January 1st.
According to Zacks, analysts expect that Kitov Pharmaceuticals Holdings will report full year earnings of ($0.40) per share for the current year. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that follow Kitov Pharmaceuticals Holdings.
COPYRIGHT VIOLATION WARNING: This article was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this article on another publication, it was copied illegally and republished in violation of United States and international copyright legislation. The original version of this article can be read at https://www.chaffeybreeze.com/2017/05/20/kitov-pharmaceuticals-holdings-ltd-ktov-expected-to-announce-earnings-of-0-21-per-share.html.
An institutional investor recently raised its position in Kitov Pharmaceuticals Holdings stock. Menta Capital LLC boosted its stake in Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) by 34.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 82,619 shares of the company’s stock after buying an additional 21,138 shares during the period. Menta Capital LLC owned about 1.08% of Kitov Pharmaceuticals Holdings worth $257,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 6.54% of the company’s stock.
Kitov Pharmaceuticals Holdings (NASDAQ:KTOV) opened at 1.72 on Monday. The stock’s market cap is $13.18 million. The stock has a 50 day moving average price of $1.90 and a 200 day moving average price of $2.56. Kitov Pharmaceuticals Holdings has a 52-week low of $1.51 and a 52-week high of $5.34.
Kitov Pharmaceuticals Holdings Company Profile
Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Kitov Pharmaceuticals Holdings Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kitov Pharmaceuticals Holdings Ltd and related companies with MarketBeat.com's FREE daily email newsletter.